How I Treat

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search

The "How I Treat" series has been published by Blood for several decades and covers a wide variety of topics in malignant and classical hematology. While these articles are not considered to be formal guidelines, they are considered highly reputable sources of expert opinion. They cover topics ranging from commonly encountered hematologic conditions with a large evidence base, to very rare conditions with only case reports to guide treatment. The purpose of this page is to consolidate the links to all known published How I Treat articles.

In the first two sections (malignant hematology and classical hematology), articles are presented by condition, in reverse chronological order. In the third section, articles are gathered under "special considerations" such as pregnancy and hematologic disease. The fourth section contains miscellaneous topics that do not easily fit into the above categories. Given the rapid change in evidence in many areas of hematology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.

Malignant hematology

Acute leukemias

Mixed-phenotype acute leukemia (MPAL)

Myeloid neoplasms

Acute lymphoblastic leukemia (ALL)

Acute myeloid leukemia (AML)

Acute promyelocytic leukemia (APL)

Chronic myeloid leukemia (CML)

Chronic myelomonocytic leukemia (CMML)

Essential thrombocythemia (ET)

Hypereosinophilic syndrome (HES)

Myelodysplastic syndrome (MDS)

Myelofibrosis (MF)

Polycythemia vera (PV)

Systemic mastocytosis

Lymphoid neoplasms

Adult T-cell leukemia-lymphoma (ATLL)

Anaplastic large cell lymphoma

Burkitt lymphoma (BL)

Castleman disease

Chronic lymphocytic leukemia (CLL/SLL)

Classical Hodgkin lymphoma (cHL)

CNS lymphoma

Cutaneous T-cell lymphoma (CTCL)

Diffuse large B-cell lymphoma (DLBCL)

Follicular lymphoma (FL)

High-grade B-cell lymphoma (HGBL)

HIV-associated lymphoma

Large granular lymphocytic leukemia (T-LGL)

Mantle cell lymphoma (MCL)

NK- and T-cell lymphoma (NKTCL)

Nodular lymphocyte-predominant Hodgkin lymphoma (NLP-HL)

Peripheral T-cell lymphoma (PTCL)

Post-transplant lymphoproliferative disorder (PTLD)

Primary mediastinal B-cell lymphoma (PMBCL)

Prolymphocytic leukemia (T-PLL)

Splenic lymphoma

Transformed lymphoma

Waldenström macroglobulinemia (WM)

Plasma cell dyscrasias

Light-chain (AL) amyloidosis

MGUS

Multiple myeloma (MM)

Plasma cell leukemia (PCL)

Smoldering multiple myeloma (SMM)

Histiocytic disorders

Hemophagocytic lymphohistiocytosis (HLH)

Langerhans cell histiocytosis (LCH)

Classical hematology

Hemostasis and thrombosis

Acquired thrombotic thrombocytopenic purpura (aTTP)

Antiphospholipid antibody syndrome (APS)

Arterial thromboembolism (ATE)

Disseminated intravascular coagulation (DIC)

Hemophilia

Heparin-induced thrombocytopenia (HIT)

Thrombotic microangiopathy (TMA)

Venous thromboembolism (VTE)

von Willebrand disease (vWD)

Cytopenias

Acquired pure red cell aplasia

Anemia

Aplastic anemia

Autoimmune cytopenia

Immune thrombocytopenia (ITP)

Neutropenia & leukopenia

Thrombocytopenia and platelet dysfunction

WHIM syndrome

Hemoglobinopathies

Beta thalassemia

Sickle cell disease

Hemolytic disorders

Cold agglutinin disease (CAD)

Atypical hemolytic uremic syndrome (aHUS)

Paroxysmal nocturnal hemoglobinuria (PNH)

Warm autoimmune hemolytic anemia (WAIHA)

Special considerations

Age-based recommendations

The majority of How I Treat articles focus on "standard" adults; below, articles that focus on other age populations are concatenated.

Neonates

Children

Adolescents and young adults (AYA)

Older adults

Complications of treatment

Bleeding

Cardiovascular complications

Immune effector cells toxicity management

Infectious complications

Iron overload

Medication toxicities

Neurologic medications

Genetic risk

Gynecologic considerations

Menstruation

Pregnancy

Postpartum period

Hospitalization

Regional considerations

Surgical considerations

Transplantation

Allogeneic HSCT

Autologous HSCT

Graft versus host disease (GVHD)

Miscellaneous

Atrial fibrillation

Cryoglobulinemia

Immunodeficiency

Common variable immune deficiency (CVID)

Severe combined immunodeficiency (SCID)

Priapism

Protoporphyria

T-cell chronic active Epstein-Barr virus disease (CAEBV)